237069-83-9 Usage
Description
2-FLUORO-3-(TRIFLUOROMETHYL)CINNAMIC ACID is a chemical compound with the molecular formula C10H5F4O2. It is a derivative of cinnamic acid, containing a fluorine atom and a trifluoromethyl group attached to the cinnamic acid molecule. This unique structure endows it with distinct properties, making it a valuable compound in various scientific fields.
Used in Pharmaceutical Research:
2-FLUORO-3-(TRIFLUOROMETHYL)CINNAMIC ACID is used as a building block for the synthesis of more complex organic molecules. Its unique structure and properties make it a valuable tool in the development of new drugs and therapeutic agents, contributing to the advancement of medicine.
Used in Materials Science:
2-FLUORO-3-(TRIFLUOROMETHYL)CINNAMIC ACID may also have potential applications in the field of materials science. Its distinct chemical structure could be utilized to create novel materials with specific properties, enhancing the capabilities of existing materials or creating new ones.
Used in Organic Synthesis:
In the realm of organic synthesis, 2-FLUORO-3-(TRIFLUOROMETHYL)CINNAMIC ACID serves as a key intermediate. Its unique chemical structure allows for the creation of a variety of organic compounds, broadening the scope of chemical reactions and products that can be synthesized.
Check Digit Verification of cas no
The CAS Registry Mumber 237069-83-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,7,0,6 and 9 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 237069-83:
(8*2)+(7*3)+(6*7)+(5*0)+(4*6)+(3*9)+(2*8)+(1*3)=149
149 % 10 = 9
So 237069-83-9 is a valid CAS Registry Number.
237069-83-9Relevant articles and documents
PHARMACEUTICALLY ACTIVE BENZOXAZOLE, BENZTHIAZOLE AND BENZIMIDAZOLE ACID DERIVATIVES
-
Page 41, (2010/02/07)
Compounds of formula (I): wherein R1, R2 and R3 are independently, hydrogen, halogen, CF3, OR6, NR7R8, NR8COR10, NR8SO2R10 or C1-6 alkyl optionally substituted by hydroxy, C1-6 alkoxy or NR7R8; R4 is NR8CONR8R9, NR8COR9, NR8SO2R9, or W-CONR8R9, where W is a bond, C1-6 alkylene, C2-6 alkenylene or C2-6 alkynylene; and R5 is Formula (A) methods for their synthesis, pharmaceutical compositions comprising them and their use in medicine, in particular for the treatment of cancer.